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Abstract
Chronic venous insufficiency is one of the most common disorders of the vascular system, affecting approximately 
50% of adults. If left untreated it can lead to a number of complications, including venous ulceration and venous 
thrombosis. This review paper outlines the epidemiology and ethiopathogenesis of the disease with regard to hemo-
dynamics and microcirculation disturbances. It describes the medical treatment as well as the traditional surgical 
approach to varicose veins (with several modifications of this technique), and its limitations and contraindications. 
Furthermore, it discusses a number of new, minimally invasive treatment methods, namely thermal in form (radio-
frequency ablation, endovenous laser ablation, steam ablation) and nonthermal (sclerotherapy, echosclerotherapy, 
Clarivein, Sapheon). For each method, there is a brief historical overview, a description of its mechanism of action, 
and its indications and limitations. The results of comparative studies on individual treatment methods as well as 
meta-analyses on this topic are briefly discussed. This paper highlights the progressive trend towards minimally 
invasive methods and attempts to predict the further development (Adv Clin Exp Med 2015, 24, 1, 5–14).
Key words: varicose veins, laser ablation, radiofrequency ablation, sclerotherapy, surgical management of varicose 
veins.
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For many years, chronic venous disease has 
been considered a merely cosmetic or psycholog-
ical problem. However, research on this disorder 
points to its serious consequences such as absence 
from work, discomfort, pain, and an objectively 
measured decline in quality of life [1]. 
The various stages of the condition are clas-
sified by the CEAP classification. In stage C1, the 
disease manifests itself as spider veins and reticu-
lar veins [2]. Stage C2 includes uncomplicated var-
icose veins. The more advanced stages of the dis-
ease are referred to as chronic venous insufficiency. 
In stage C3 oedema, without skin changes, is pres-
ent. Advanced skin lesions such as lipodermato-
sclerosis or trophic changes (C4) as well as healed 
(C5) and active ulcerations (C6) are complications 
seen in more advanced stages. Consequently, it can 
lead to the loss of the affected limb, and can even 
be life threatening [3]. 
The real social significance of chronic venous 
insufficiency lies in its prevalence and in the cost 
of the treatment spread out over many years. Ep-
idemiological studies conducted in Poland, which 
included more than 40,000 patients, indicate that 
the disease affects 61% of women and 38% of men 
in the adult population [4]. Some epidemiological 
studies indicate less variation in the incidence of 
the disease between the sexes, whereas others sug-
gest an inverse proportion [5].
The most severe stage, active venous ulcer-
ation, affects less than 1% of the population (in 
Poland this is observed in up to 0.5% of adults), 
but is seen in 3% of patients over age 65 [6]. The 
incidence of varicose veins increases with age, as 
M. Chwała et al.6
it is a chronic degenerative disease. As the popu-
lation’s life expectancy increases we can expect to 
see an increase in the incidence of the disease. One 
of the consequences will be an increase in the cost 
of treatment of the disease and its complications.
The Mechanism  
of Venous Blood Return
The return of venous blood from the lower ex-
tremities is dependent on a number of factors. Hu-
man upright posture necessitates mechanisms that 
assist in emptying the venous vessels. Deep veins 
are located between the large muscle groups in-
side the myofascial compartments. In normal con-
ditions, during muscle contractions, pressure gen-
erated within the fascial compartment is directly 
transferred to the veins, directing venous blood 
flow towards the heart through competent venous 
valves. During increased effort, the pressure can 
reach up to 5 bars [7]. Due to this mechanism, over 
90% of venous blood volume leaves the lower limb 
via the deep vessels. Located outside of the fascia, 
superficial vessels are connected to the deep venous 
system via the sapheno-femoral and sapheno–pop-
liteal junction and perforator veins. Their task is to 
drain venous blood from the skin and subcutaneous 
tissue. The direction of the blood flow from the su-
perficial to the deep venous system is maintained by 
the existing pressure differences and the Bernoul-
li effect, in which a drop in the pressure resulting 
from accelerated blood flow in the deep veins causes 
sucking of the blood from the superficial veins.
If a healthy person of average height stands still 
for a few minutes, hydrostatic pressure in the venous 
system of the foot reaches about 120 cm of the water 
column. Achieving such pressure values is accom-
panied by discomfort and causes involuntary mus-
cle contractions (activation of the muscle pump). 
Both involuntary and voluntary muscle pump ac-
tivation results in a pressure drop of approximate-
ly 60%. Thus, a properly functioning muscle pump 
prevents an increase of pressure in the standing po-
sition. As a result, the pressure at the venous end of 
the capillary is at a similar level to a supine position.
On the contrary, in venous insufficiency the 
pressure after marching or standing on tiptoes is 
not adequately reduced and/or its high value is re-
stored after only a short period of stillness (Fig. 1).
Microcirculation
The delicate structure of microcirculation does 
not tolerate high hydrostatic pressure. The protec-
tive mechanisms are located in the “high pressure”, 
i.e. arterial side, where precapillary sphincters and 
arterioles can be found. But microcirculation is not 
in any way protected against blood pressure fluctu-
ations from the venous side. Therefore it requires 
precise mechanisms for ‘pumping out’ the venous 
blood in order to avoid microcirculation “over-
flow”. Otherwise a disturbed pressure profile from 
the venous side is directly transferred into micro-
circulation leading to a sequence of events, such as 
endothelial cell activation, extravasation of macro-
molecules and red blood cells, immune system ac-
tivation, and leukocyte diapedesis. The consequent 
chronic inflammation leads to tissue damage, in-
cluding tissue necrosis and ulceration [8].
Varicose Veins
Primary varicose veins are one of the manifes-
tations of chronic venous disease. Degeneration of 
trunks and valves leads to an abnormal flow of ve-
nous blood from the deep venous system to the su-
perficial system and a flow downwards in the su-
perficial system itself. Thus, blood flow generated 
in the deep venous system cephalad is undermined 
by the opposite direction of the flow in superficial 
veins, where the blood flows down as if via ‘gut-
ters’. Consequently, after being drained by muscle 
contractions, the venous system is quickly refilled 
up to a maximum hydrostatic pressure with blood 
flowing through insufficient superficial vessels. 
The greater the diameter of the insufficient trunks, 
the faster the maximum pressure is reached. More-
over, the deep vein system needs to ‘pump in’ the 
Fig. 1. The influence of the muscle pump on the pres-
sures changes in a superficial venous system in healthy 
adults and patients with chronic venous insufficiency. 
In healthy subjects the drop in pressure after pump 
activation is greater and the time required to refill the 
vascular bed (RF-refilling time) is longer. 
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same blood. This volume overload, if maintained 
for many years, leads to secondary irreversible 
changes in the deep venous system.
Medical Treatment
Therapeutic management of chronic venous 
disease can be based on conservative (medical) or 
invasive methods.
Medical treatment of chronic venous disease 
involves the use of the following:
– lifestyle changes (weight loss, exercise, pe-
riodic limb elevation, rehabilitation of the ankle 
joint, avoidance of a  standing position and a  sit-
ting position with lowered limbs) 
– compression therapy –  using compression 
bandaging or graduated compression products, 
when properly selected, effectively reduces edema 
and pain. However, their tolerance may be prob-
lematic, especially in the summer. 
– pharmacotherapy – phlebotropic drugs, act-
ing primarily by modifying the venous tone, reduce 
the severity of inflammation and vascular perme-
ability of capillary vessels, which in turn leads to 
a decrease in pain, symptoms and edema. 
Invasive Treatment
The essence of invasive treatment of venous 
insufficiency in more advanced stages (CEAP C2 
and above) lies in breaking the circuit of venous 
vessels in which reflux is present. Additionally, 
a Doppler examination of the deep venous system 
to confirm vessel patency is necessary prior to in-
vasive treatment. Currently, there are no known 
effective methods for repairing insufficient valves 
except for therapies that are still in the experimen-
tal phase. However, a number of new methods are 
worth mentioning, including attempts to transfer 
a healthy autologous valve mounted within a self- 
expanding stent to the insufficient vessel [9]. Rec-
ognizing varicose veins as closed circuits justi-
fies either the selective ablation of an inefficient 
trunk or solely of a varicose vein as a final form of 
treatment: 
– Ablation of the trunk of an insufficient 
great/small saphenous vein often leads to the com-
plete regression of varicose veins due to the lack of 
inflow ‘from the top. 
– Alternatively, closing varicose veins may re-
sult in the disappearance of reflux in the great sa-
phenous vein (because the blood has no space to 
drain). 
– More severe stages require the removal of 
both of the above components along with re-entry 
perforators. Treatment can therefore be divided 
into correcting reflux in the venous trunks and re-
moving the varicose veins (Fig. 2).  
Surgical Methods 
Surgical (traditional) treatment is the oldest 
method for dealing with varicose veins. The op-
erating technique was developed in 1905 by Wil-
liam Wayne Babcock and is still used with some 
modifications. 
In the most common case of great saphenous 
vein (GSV) insufficiency, the procedure starts with 
a  skin incision in the sapheno–femoral junction 
region. All the tributaries of the greater saphenous 
vein near its ostium must be located and dissect-
ed. Eventually, the saphenous vein itself should 
be dissected, its end flush ligated with the femo-
ral vein, leaving the shortest possible vein stump 
–  this part of the procedure is called a crossecto-
my. Subsequently, another skin incision should 
be made along the course of the saphenous vein. 
Currently, this is most commonly done at or just 
below the knee. A  stripper –  a  metal probe with 
a bulbous tip –  is placed inside the vein, and the 
tip of the stripper emerges at the free end of the 
vein in the inguinal region. After the fixing, the sa-
phenous vein is removed. Nowadays, in most cases 
only the femoral section of GSV is removed, leav-
ing the vein in the lower leg. This approach is asso-
ciated with lower risk of post-procedure neurolog-
ical complications, and the remaining fragment of 
the vein may serve as a conduit for future vascular 
Fig. 2. Surgical methods used in varicose vein treat-
ment with respect to inefficient major vessel trunks (1) 
and varicose veins (2). EVLT – endovenous laser treat-
ment, RF – radiofrequency, SVS – steam vein sclerosis, 
TIPP – transilluminated powered phlebectomy.
M. Chwała et al.8
or cardiac surgery. To reduce the invasiveness of 
the procedure the technique of invagination strip-
ping can be performed –  the free end of the vein 
fixed on the stripper is inserted ‘inside’ the vessel, 
and the vein is removed in a similar way to a fin-
ger being pulled out of a rubber glove, or a stock-
ing stripped ‘inside out’.
Cryostripping is the alternative. In this meth-
od, after performing a  crossectomy, the probe is 
inserted into the saphenous vein peripherally up to 
the level of the knee. Then, the ending of the probe 
supplied with liquid nitrogen is cooled off, causing 
the saphenous vein to freeze up to the tip. The dis-
tal section of the removed vein breaks, while the 
proximal part is removed together with the probe, 
similarly to stripping by invagination.
Low temperatures decrease the bleeding from 
the tributaries along the course of the GSV, there-
by reducing the risk of hematomas. Importantly, 
another incision in the limb can be avoided, apart 
from access to the saphenofemoral junction [10].
In conventional surgery, as a  complement to 
the stripping technique, varicose veins are most 
often removed simultaneously. A small incision is 
made along the course of the varicose vein every 
few centimeters in order to extract them above the 
skin using a special hook; the vessel is divided, and 
both formed ends of the vein are ripped off (so- 
called hook phlebectomy, miniflebectomy). In-
sufficient perforators are treated in an analogous 
manner. If incisions are suitably small, wounds 
can be left without skin sutures, resulting in a bet-
ter cosmetic effect.
A modification of this method is transillumi-
nation powered phlebectomy (TIPP), which in-
volves mechanically removing the varicose veins. 
Inserted by puncturing into subcutaneous tissue, 
the transilluminator (strong light source) helps 
locate varicose veins, which are then broken into 
pieces and sucked out by a  special tip [11]. Vari-
ces are removed with fewer incisions, and may be 
removed from areas in close proximity to venous 
ulcers without the risk of infecting wounds, as the 
tip of the device can be inserted under the skin at 
a reasonable distance from the wound. The disad-
vantages include the price of the equipment, skin 
recesses formed as a  result of adipose tissue suc-
tion, and skin discoloration.
Importantly, conventional surgery has no lim-
itations in terms of size, location and course of the 
vessels to be operated on. In Poland, it remains the 
only form of treatment refunded by the National 
Health Fund.
The main complications of surgical treatment 
are postoperative pain and hematomas, especial-
ly along the course of a  saphenous vein removed 
via stripping, resulting from disruption of the 
tributaries. Wound infection and sensory distur-
bances due to the removal of skin nerves have also 
been observed. 
Postoperative scarring undermines the cos-
metic result of the treatment. Rare complications 
include damage to the arterial system in the ingui-
nal region, damage to deep veins, and deep vein 
thrombosis [12].
The major problem associated with surgical 
treatment is the risk of relapse. The reported rate of 
relapse at 5 years varies between 50 and 65% [13]. 
According to the international consensus on post-
surgical recurrent varicose veins (REVAS) [14]
 
ap-
proved in Paris in 1998, there are several types of 
recurrent varicose veins. Despite proper surgical 
treatment, veins that were “healthy” at the time of 
the initial surgery may degenerate over time. The 
progression of the disease is responsible for be-
tween 20% and 25% of the relapses described in 
the literature [15].
Varicose veins that appear up to a month after 
the surgery most frequently result from an inad-
equate technique or tactic (e.g. leaving one of the 
insufficient trunks in place, an overly long GSV 
stump with tributaries, removal of the incorrect 
venous trunk). Another term used to describe this 
pathology is residual varicose veins. Only those 
varicose veins that were formed in the area affect-
ed by the surgical procedure at least one month af-
ter the surgery can be regarded as real recurrent 
varicose veins.
Initially, it was thought that as with residual 
varicose veins, the majority of recurrences could 
be regarded as a  consequence of poor surgical 
technique. However, with the prevalence of ultra-
sonography it was found that a significant percent-
age of recurrences occur despite adequate surgical 
treatment. The process responsible for the forma-
tion of recurrent varicose veins was defined as neo-
vascularization. Over a period of several years, new 
blood vessels form in patients postoperatively and 
these eventually take over the function of the re-
moved insufficient trunk vein –  most commonly 
the great saphenous vein. Studies using ultrasound 
indicated the presence of such vessels in 14% of pa-
tients one year after surgery [16]. Neovasculariza-
tion appears to be responsible for between 8 and 
60% of secondary varicose veins [17].
The vessels formed during neovascularization 
have an immature and incomplete wall structure 
(neither media nor adventitia present), and do not 
have valves. The wall is thin, and the course is sin-
uous (hence the common term used to describe 
changes visible in the ultrasound in the groin is 
cavernous angioma –  cavernoma). From a  histo-
logical point of view, the vessels have neither elas-
tic fibers in their walls nor nerve fibers, and are 
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surrounded by scar tissue [18]. These are formed 
by the budding of the vascular endothelium at the 
edges of veins cut during surgery, in a process that 
probably involves released growth factors, metal-
loproteinases, hypoxia, a venous pressure gradient, 
and local inflammation. To some extent, the neo-
vascularization process may be regarded as an ab-
erration of normal neoangiogenesis in granulation 
tissue formed in the surgical wound [19]. Venous 
lesions formed as a  consequence of neovascular-
ization not only decrease the patient’s satisfaction, 
but are also regarded as posing considerable tech-
nical difficulties in the case of re-operation. They 
increase the perioperative risk, and the effect of the 




Some techniques are more likely to induce 
neovascularization than others. In the intravascu-
lar methods there is no disruption in the vascular 
continuity, therefore no endothelial exposure, scar-
ring, granulation tissue, or hematoma formation. 
The results confirm a  reduced risk of neovascu-
larization following non-surgical treatments. The 
percentage of neovascularization after endovascu-
lar treatment is between 1% and 1.5%. One pro-
spective study showed that no neovascularization 
was observed five years after treatment for great 
saphenous vein reflux with radiofrequency [21].
Intravascular techniques damage the venous 
wall, resulting in fibrosis and clot formation. 
A damaging agent – thermal, electrical, chemical, 
mechanical, or a combination of these – is usual-
ly applied through a  small puncture without the 
need to prepare a vein. However, in order to locate 
a  vein, ultrasound navigation becomes necessary. 
Positioning in relation to the junction with deep 
veins is also based on ultrasonography techniques. 
Thus current revival in intravascular techniques is 
in part a  consequence of technological advances 
and a drop in the price of ultrasound devices.
Besides the absence of scarring and the avoid-
ance of neovascularization, another potential ben-
efit of alternative treatments is the low risk of infec-
tion. This makes it possible to use local anesthesia 
and to operate on patients with active ulcerations. 
It also facilitates a  two-stage approach (first, ei-
ther the great or small saphenous vein trunks are 
closed and then, after a time interval, the varicose 
veins may be dealt with, only if spontaneous in-
volution did not occur first). Faster convalescence 
and shorter absence from work following intravas-
cular procedures are also important factors.
The non-surgical methods can be classified in-
to thermal techniques, which require the use of an-
esthesia and intumescence, and nonthermal tech-
niques. The first group consists of endovenous 
laser ablation (EVLT), radiofrequency ablation 
(RF), and steam vein sclerosis (SVS). The second 
group comprises sclerotherapy, echosclerotherapy, 
the Sapheon method, and the ClariVein method.
A number of pioneering intravascular ablation 
procedures were performed in Krakow, Poland in 
the 1960s by a  team headed by Prof. Politowski. 
These procedures were performed using a  stan-
dard electrocoagulation kit with the appropriate 
tip inserted into the great saphenous vein after its 
dissection  [22]. Unfortunately, the technique was 
abandoned due to postsurgical complications and, 
from today’s perspective, no appropriate imaging 
facilities.
Intravascular procedures began to develop on 
a  larger scale after the year 2000. One of the first 
reports on this subject describes a great saphenous 
vein closure technique using radiofrequency (RF) 
waves [23].
The method is based on the phenomenon of 
heat generation in the tissues around the conduc-
tor in which a  current alternating in radio fre-
quency (300 KHz to 1  MHz) flows. A  current at 
such a high frequency does not trigger potentials 
in excitable cells. As a consequence, the RF proce-
dure is less painful and does not cause secondary 
muscle contractions. The temperature of 85–120 
degrees generated around the probe destroys the 
endothelium with secondary vasoconstriction, the 
coagulation of blood in the vessel lumen, and the 
denaturation of proteins in the vein wall, leading 
in turn to its permanent occlusion. Over time, the 
vein undergoes fibrosis and an ultrasound reveals 
an image of thin bands of connective tissue (fi-
brous cord).
The procedure involves puncturing the vein to 
be treated under ultrasound guidance, and insert-
ing a vascular sheath (Seldinger’s method) into the 
vein. The most common vein to be punctured is 
the great saphenous vein near the knee (where it 
is easy to locate, has a relatively simple course, and 
is not accompanied by a saphenous nerve). Subse-
quently, a catheter is inserted into the vessel with 
an RF tip, and the catheter tip under ultrasound 
control is positioned approximately 2  cm distally 
from the saphenofemoral junction.
Tumescent anesthesia is also performed un-
der ultrasound control. In this method, a  large 
volume of liquid is injected into the tissues sur-
rounding the treated vein along its course. This 
creates a  secure barrier separating the vein from 
the surrounding tissue (in particular from the ad-
jacent deep veins, nerves and away from the skin), 
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and increases the adhesion of the venous wall to 
the catheter. Since the fluid contains an anesthetic 
substance, an analgesic effect is achieved. In order 
to drain superficial veins of blood, the limb being 
operated on is raised up. Subsequently, vein ab-
lation is performed along its entire length as the 
catheter is gradually withdrawn.
The latest devices allow simultaneous coagula-
tion of a vein segment up to 7 cm in length, while 
the device monitors the temperature of the cath-
eter tip (about 120 degrees Celsius), and the time 
of energy application (sound pulse emitted every 
20 s). Next, the catheter is advanced a further 7 cm. 
This technique allows for a very precise and repro-
ducible dosage of energy (Venefit TM procedure 
using Covidien ClosureFast TM catheters). Oth-
er devices require continuous movement of the tip 
(e.g. a bipolar Olympus Celon probe, which oper-
ates at a much lower temperature of 85 degrees). 
Currently, there is no data in the literature com-
paring both methods. The effectiveness achieved 
by the RF procedure reaches 93% of closed veins 
within 3 years [24].
When the RF method was compared with the 
EVLT (980 nm laser ablation) improvement ac-
cording to the Venous Clinical Severity Scores 
(VCSS) and the CVIQ2  questionnaire evaluating 
the quality of life was faster after the former. Less 
severe pain and fewer complications were also not-
ed in patients treated with RF [25].
Possible complications following RF treatment 
include bleeding, infections, thermal damage to 
the nerves (in particular the saphenous nerve and 
the sural nerve), deep vein thrombosis, and skin 
discoloration. Because of the specific construction 
of the RF catheter, introducing it through the tor-
tuous sections of the veins and post-thrombotic 
vessels can be difficult.
Another method for treating varicose veins is 
based on the use of laser light –  this is called en-
dovenous laser ablation (EVLT) [26]. From a tech-
nical point of view, it is similar to RF treatment. 
The advantage of the laser approach is the pres-
ence of a so-called pilot, i.e. a red spot of light vis-
ible through the skin at the end of the fiber, allow-
ing for the positioning of the tip, in addition to the 
ultrasound. In contrast to RF, it is not possible to 
monitor the temperature or the energy dose deliv-
ered in laser surgery. It is determined empirical-
ly on the basis of the laser power and the speed at 
which the fiber is pulled. The values recommend-
ed for the 810  nm laser oscillate between 50 to 
80 J/cm [27] (e.g. when the power is set at 14 watts, 
the tip of the optical fiber should move 1  cm in 
5 s). The laser light causes a local increase in tem-
perature of up to 800 degrees Celsius at the top of 
the fiber. As a  result, in addition to the fact that 
the vein wall is directly exposed to laser light, there 
is also a  significant increase in blood tempera-
ture around the optical fiber and the blood boils 
(steam bubbles visible on ultrasound examina-
tion). The high temperature transferred by blood 
damages the vein wall evenly within the short seg-
ment. As a  result of both processes the endothe-
lium becomes completely destroyed, the collagen 
in the vessel wall is denaturated, and its lumen co-
agulated  [28]. The laser wavelengths of 810, 940 
and 980 nm, that were introduced initially, are ab-
sorbed by deoxyhemoglobin, which results most-
ly in heating of the blood. Direct action of these 
wavelengths on the vessel wall is weaker. The light 
of the recently introduced (BiolitecTM) 1470 nm 
lasers is absorbed by the water contained in the tis-
sue and it acts more selectively on the venous wall. 
Thus, lower energy doses can be used to cause vein 
closure, which results in decreased levels of pain in 
the postoperative period and a  lower risk of per-
forating the vessel wall, reducing postoperative 
haematomas.
Besides the introduction of various wave-
lengths, the evolution of lasers techniques involves 
modifications to optical fibers. Apart from classical 
optical fibers with a diameter of 200–600 microns, 
which beam light “forward”, companies have also 
introduced so-called radial optical fibers equipped 
with a special tip capable of changing the direction 
of the laser beam so that they also illuminate “side-
ways”, forming a ring of light 360 degrees around 
the fiber. As a result, the direct impact on the vein 
wall is increased, which makes it possible to close 
a vessel with a larger diameter. It also reduces the 
risk of vein wall perforation by the beam focused 
in front of the fiber.
EVLT complications and limitations are sim-
ilar to those present in radio frequency ablation. 
In the case of EVLT, there is a greater risk of the 
vein being perforated and hence an increased risk 
of hematoma. Furthermore, the pain experienced 
is slightly more severe, which is most likely due to 
the much higher temperatures achieved during la-
ser treatment [29]. At the same time, the method 
is more effective [30].
The most recent thermal method of treatment 
is steam therapy (SVS Steam Vein Sclerosis). On 
the basis of indirect action of EVLT due to the 
formation of steam bubbles transmitting energy 
to the venous wall, a device has been designed to 
generate steam pulses heated to a  temperature of 
120 degrees Celsius. The steam is delivered to the 
vein by a catheter. The procedure is analogous to 
RF and EVLT. By dissipating its energy, the steam 
immediately condenses while 1 g of steam during 
condensation transfers 2258 J.  Therefore, assum-
ing the need to deliver about 50 J  of energy per 
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one centimeter of vein, steam generated from just 
2  ml of water is sufficient to close a  30  cm long 
section of the great saphenous vein. Steam bub-
bles produced by the generator have fixed param-
eters – 76 microliters of water is used to produce 
a single pulse. Thanks to this, the amount of ener-
gy is strictly controlled. Steam impulses are gen-
erated every centimeter along the catheter route. 
The catheter is thin (1.2 mm diameter) and flexi-
ble; therefore, it can be used to close varicose veins 
and perforators. Due to these benefits, a complete 
operation can be performed by means of steam 
without the need for additional miniflebectomy or 
sclerotherapy, nor a second stage flebectomy. The 
method is promising, but there is insufficient data 
supporting its long-term effectiveness [31].
Nonthermal methods constitute another ap-
proach to varicose vein treatment. One of the ad-
vantages of these techniques is that no anesthesia is 
needed, which decreases the risk of the procedure. 
By omitting intumescence, additional numer-
ous punctures and secondary hematomas can be 
avoided. As no high temperature is used, there is 
no risk of skin burns or damage to the nerves and 
muscles adjacent to the ablated veins. This contrib-
utes to reduced perioperative pain.
From a  historical point of view, sclerothera-
py offered the first alternative to classical surgery. 
This approach was based on observations of id-
iopathic varicose vein thrombosis, which showed 
that during the course of the disease, some patients 
experienced reduced symptoms due to fibrosis and 
secondary occlusion of varicose veins. This led to 
efforts to find a  substance that would cause ster-
ile inflammation in the vein. This approach, com-
bined with compression therapy, leads to irrevers-
ible vein fibrosis. Various groups of chemicals 
were used to obliterate varicose veins, such as hy-
perosmotic agents (saline solution or glucose), irri-
tants (chromed glycerol), and detergents. The lat-
ter group currently includes the most widely used 
substances, i.e. tetradecyl sulfate (STD) and Polido-
canol (Aetoxysclerol). The sclerotherapy involves 
injecting sclerosant into the target vessels. Deter-
gents cause damage of the vascular endothelium, 
which results in the exposure of the vessel’s deeper 
layers. The vessel contracts immediately, followed 
by thrombus formation and sterile inflammation 
of the vascular wall. This method is now safer due 
to the introduction of detergents that do not have 
a strong cytotoxic effect (they remove endothelial 
cells by dissolving intercellular connections). Con-
sequently, the risk of tissue necrosis following the 
accidental administration of the medicine outside 
the target area is minimal.
When large venous vessels are obliterat-
ed, painful lumps can form along closed veins, 
usually approximately two weeks after the proce-
dure. These consist of blood clots formed in the 
vessel and secondary breakdown products of red 
blood cells with the osmotic properties. In the 
above situation, the vessel is punctured, there-
by draining its semi-liquid content (sclerothrom-
bus). External pressure applied to obliterated ar-
eas immediately after treatment aims to minimize 
the above consequences. Sclerosant activity is re-
stricted solely to the superficial veins due to its 
rapid deactivation by plasma proteins and imme-
diate dilution of the drug by the large amount of 
blood flowing through the deep venous system. 
These two mechanisms prevent the vessels from 
causing deep vein thrombosis; however, for many 
years they have also been the main factors limiting 
the efficacy of the method (especially when larger 
venous trunks with a rapid blood flow were to be 
treated) [32]. Elevating the limb and using the so-
called air-block technique, i.e. the administration 
of a  small volume of air into the vessel in order 
to displace blood, helped solve this problem. The 
sclerosant injected afterwards is consequently un-
diluted and able to affect the wall more efficiently, 
encouraging a local effect.
However, sclerotherapy only really achieved 
its renaissance after the introduction of the foam 
method. Due to the chemical properties of deter-
gents, they have the ability to form a  foam when 
mixed with air or other gases. The foam distrib-
utes in the vessel, displaces the blood, and remains 
at the injection site. As a  result, the potency of 
foam is several times higher than that of the drug 
in the liquid form. The ability to control the area in 
which the foam is active is also better, and penetra-
tion into the deep venous system is slower.
The next step in the development of sclerother-
apy came with the implementation of ultrasound 
technology. Foam is an excellent ultrasound con-
trast agent, so its position in the vessel and the area 
of its operation can easily be controlled. Moreover, 
thanks to the support of ultrasound it was possi-
ble to access deeper vessels, invisible through the 
skin. This allowed for a comprehensive approach 
to treating varicose veins, regardless of the sever-
ity of the disease.
Sclerotherapy was previously used mostly in 
the treatment of spider veins, telangiectasia, and 
reticular veins. Discouragement concerning treat-
ment of varicose veins resulted from common re-
currence of the problem, mainly caused by leaving 
untreated saphenous vein trunks (great or small). 
Foam sclerotherapy with ultrasound guidance, al-
so referred to as echosclerotherapy, enabled clos-
ing trunks as large as 10  mm in diameter. Its ef-
fectiveness is comparable to surgical methods and 
is slightly worse than thermal treatment. Other 
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advantages of sclerotherapy include its relative-
ly low price and the fact that it can be adminis-
tered in an outpatient setting. Sclerotherapy is also 
an excellent method for treating recurrent varicose 
veins – due to their sinuous course, wall structure, 
and the coexistence of scars that prevent the use of 
RF and lasers, as well as the increased risk of clas-
sical operations. The disadvantage of sclerotherapy 
is that there is a risk of long-lasting discoloration 
of the skin in the vicinity of the closed vessels. Be-
cause of the need to remove hematomas and the 
need to repeat the procedure due to the limit-
ed amount of the drug that can be administered 
safely, the treatment is a lengthy process and often 
takes several weeks. Potential complications of the 
treatment include venous thrombosis (activation 
of the coagulation system during sclerotherapy has 
been proven), allergic reactions, and tissue necro-
sis. The most serious complications occur with ac-
cidental intra-arterial administration, which may 
lead to necrosis of the limb, possibly necessitating 
secondary amputation of the limb. Specific com-
plications of the foam method result from migrat-
ing gas bubbles. Most of the time they will end up 
in the pulmonary circulation, however in the pres-
ence of a  patent foramen ovale (PFO), they can 
migrate to the systemic circulation. In such cases, 
they can cause damage to the central nervous sys-
tem, resulting in temporary visual disturbances, 
headaches, and in very rare cases, a stroke. Accord-
ing to another theory, neurological complications 
occur due to post-procedural increased endothelin 
activity, which affects the cerebral vessels [33]. Be-
cause foam sclerotherapy is not FDA approved it 
is still treated as an off – label method in the USA, 
and alternative methods are being sought.
“ClariVein” method enhances the action of the 
chemical sclerosant through mechanical damage 
and irritation of the venous wall. The author of this 
method uses the analogy of a  washing machine, 
which also mechanically increases the penetration 
of the detergent, and thus enhances its strength. 
Developed in 2005, the mechanochemical method 
of vein ablation involves the use of a catheter with 
a rotating tip. The procedure is similar to that for 
EVLT or RFA. A flexible catheter with a 2 cm long 
elastic wire at its end is inserted 2 cm below the sa-
phenofemoral junction. Subsequently, elastic wire 
at the end of the catheter rotates with a  frequen-
cy of 3500 rpm in a circular motion, damaging the 
endothelium and causing intense contraction of 
the vein. At the same time, a  liquid sclerosant is 
applied from the catheter just below the rotating 
tip. The tip is pulled along the vein approximate-
ly 1–2 mm per second. The advantage of this pro-
cedure is the time –  complete greater saphenous 
vein ablation takes approximately 14  min. This 
method is used to treat lower leg sections of the 
venous trunks without the risk of adjacent nerve 
damage. It does not require an external generator, 
because the grip includes a  battery-powered mo-
tor, controls the application of the sclerosant and 
is integrated with the catheter (ClariVein). The 
number of studies assessing this method is small. 
In one of them, the effectiveness was estimated at 
97% of all great saphenous vein occlusions within 
6 months [34].
In another method, “Sapheon”, an adhesive 
substance (a tissue glue derived from cyanoacryl-
ic glue), is applied into the vein lumen in order 
to obliterate the vessel. Originally, similar com-
pounds were used to obliterate the hemangiomas 
and varicose veins of the esophagus. The specif-
ic property of cyanoacrylic adhesives enables their 
rapid polymerization in the presence of water and 
their high affinity to tissue. When introduced in-
to the vein, the adhesive causes closure of its lu-
men primarily mechanically. However, the essence 
of the method is the secondary aseptic inflamma-
tory reaction caused by a  foreign body that ulti-
mately leads to fibrosis of the vein [35]. The adhe-
sive substance is applied by a catheter and it takes 
about 1.6 mL of the adhesive to treat the great sa-
phenous vein. An important feature of this method 
is the possibility of avoiding compression therapy 
after treatment since its effect is immediate. Ob-
servations indicate that the method is immediately 
100% effective (48–72 h observation), and is 97% 
effective within a month. However, current studies 
have only covered a small number of patients, and 
the observation time was short.
Conclusions
Due to its incidence, chronic venous insuffi-
ciency of the lower limbs poses a challenge to mod-
ern society. Although medical treatment helps to 
stop its progress, it is not curative. The invasive 
methods provide an improvement in quality of life, 
including improved aesthetics. They also help to 
prevent the onset of future serious consequences 
of the disease, including development of irrevers-
ible deep vein insufficiency and the progression 
to venous ulcerations  [36]. Randomized studies 
confirm the improved cost effectiveness of sur-
gical treatment in comparison with compression 
therapy [37].
It is not surprising that the number of strip-
ping-based surgical procedures carried out has de-
clined (155 000 in the U.S. in 1999, only 40 000 in 
2007). This can be explained by the growing popu-
larity of minimally invasive treatment, as the num-
ber of procedures has increased from 80,000 to 
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195,000 in just three years [38]. This is at least par-
tially due to the availability of this type of treatment 
for physicians specializing in areas other than gen-
eral or vascular surgery, such as dermatologists and 
angiologists. But a  more important reason is the 
patients’ comfort, faster recovery time, and better 
aesthetic results. Most importantly, the modern 
minimally invasive methods, as shown in a  large 
meta-analysis, are very effective with the 5-year ef-
ficacy rates ranging from 95% for EVLT, 80% for 
RF, and 74% for sclerotherapy, while traditional 
operation with stripping has 76% efficacy [39].
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[4] Jawień A, Grzela T, Ochwat A: Prevalence of chronic venous insufficiency (CVI) in men and women of Poland. 
Multicenter cross-sectional study of 40095 patients. Phlebology 2003, 18, 110–122.
[5] Evans CJ, Fowkes FGR, Ruckley CV, Lee AJ: Prevalence of varicose veins and chronic venous insufficiency in men 
and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999, 53, 149–153.
[6] Andersson E, Hansson C, Swanbeck G: Leg and foot ulcer prevalence and investigation of the peripheral arterial 
and venous circulation in a randomised elderly population. An epidemiological survey and clinical investigation. 
Acta Derm Venereol 1993, 73, 57–61.
[7] Raines JK, Almeida JI: Role of Physiologic Testing in Venous Disorders in: Bergan JJ The Vein Book, Academic 
Press, Waltham 2006, 47, 1st ed.
[8] Kistner RL, Eklof B: Classification and etiology of chronic venous disease. In: Gloviczki P, editor. Handbook of 
venous disorders: guide-lines of the American Venous Forum. Hodder Arnold, London 2009, 37–46, 3rd ed.
[9] Phillips MN, Dijkstra ML, Khin NY, Lane RJ: Endovenous valve transfer for chronic deep venous insufficiency. 
Eur J Vasc Endovasc Surg 2013, 46, 360–365.
[10] Menyhei G, Gyevnar Z, Arato E, Kelemen O, Kollar L: Conventional stripping versus cryostripping: a prospec-
tive randomised trial to compare improvement in quality of life and complications. Eur J  Vasc Endovasc Surg 
2008, 35, 218–223.
[11] Luebke T, Brunkwall J: Meta-analysis of transilluminated powered phlebectomy for superficial varicosities. 
J Cardiovasc Surg (Torino) 2008, 49, 757–764.
[12] Lurie F, Creton D, Eklof B: Prospective randomized study of endovenous radiofrequency obliteration (closure 
procedure) vs ligation and stripping in a  selected patient population (EVOLVES Study). J  Vasc Surg 2003, 38, 
207–214.
[13] Jones L, Braithwaite BD, Selwyn D, Cooke S, Earnshaw JJ: Neovascularisation is the principal cause of varicose 
vein recurrence: results of a randomized trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg 1996, 
12, 442–445. 
[14] Perrin MR1, Guex JJ, Ruckley CV: Recurrent varices after surgery (REVAS), a  consensus document. REVAS 
group. Cardiovasc Surg 2000, 8, 233–245.
[15] Darke SG: The morphology of recurrent varicose veins. Eur J Vasc Surg 1992, 6, 512–517.
[16] De Maeseneer MG, Ongena, KP, Van den Brande F, Van Schil PE, De Hert SG: Duplex ultrasound assessment 
of neovascularization after sapheno-femoral sapheno-popliteal junction ligation. Phlebology 1997, 12, 64–68.
[17] Egan B, Donnelly M, Bresnihan M, Tierney S, Feeley M: Neovascularization: an “innocent bystander” in recur-
rent varicose veins. J Vasc Surg 2006, 44, 1279–1284, discussion 1284.
[18] Geier B, Olbrich S, Barbera L, Stucker M, Mumme A: Validity of the macroscopic identification of neovascular-
ization at the saphenofemoral junction by the operating surgeon. J Vasc Surg 2005, 41, 64–68.
[19] van Rij AM, Jones GT, Hill BG, Amer M, Thomson IA, Pettigrew RA: Mechanical inhibition of angiogenesis 
at the saphenofemoral junction in the surgical treatment of varicose veins: early results of a blinded randomized 
controlled trial. Circulation 2008, 118, 66–74.
[20] Allegra C, Antignani PL, Carlizza A: Recurrent varicose veins following surgical treatment: our experience with 
five years follow-up. Eur J Vasc Endovasc Surg 2007, 33, 751–756.
[21] Kianifard B, Holdstock JM, Whiteley MS: Radiofrequency ablation (VNUS closure) does not cause neo-vascular-
isation at the groin at one year: results of a case controlled study. Surgeon 2006, 4, 71–74.
[22] Politowski M, Szpak E, Marszalek Z: Treatment of Varicose Veins of the Lower Extremities with the aid of 
Electrocoagulation. Pol Przegl Chir 1964, 36, 7–14.
[23] Goldman MP: Closure of the greater saphenous vein with endoluminal radiofrequency thermal heating of the vein 
wall in combination with ambulatory phlebectomy: preliminary 6-month follow-up. Dermatol Surg 2000, 26, 452–456.
[24] Proebstle T: Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation 
of the great saphenous vein with or without treatment of calf varicosities. J Vasc Interv Radiol 2009, 20, 752–759.
[25] Almeida JI, Kaufman J, Göckeritz O: Radiofrequency Endovenous ClosureFast Versus Laser Ablation for the 
Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY Study). 
J Vasc Interv Radiol 2009, 20, 752–759.
M. Chwała et al.14
[26] Navarro L, Min RJ, Bone C: Endovenous laser: a new minimally invasive method of treatment for varicose veins 
e preliminary observations using an 810 nm diode laser. Dermatol Surg 2001, 27, 117–122.
[27] The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the 
Society for Vascular Surgery and the American Venous Forum. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, 
Gillespie DL, et al, Wakefield TW; Society for Vascular Surgery; American Venous Forum. J Vasc Surg 2011, 53 
(Suppl 5), 2S–48S.
[28] van den Bos RR, Kockaert MA, Neumann HAM, Nijsten T: Technical Review of Endovenous Laser Therapy for 
Varicose Veins Eur J Vasc Endovasc Surg 2008, 35, 88–95.
[29] Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B: Randomized clinical trial comparing 
endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous 
varicose vein. Br J Surg 2011, 98, 1079–1087.
[30] Luebke T, Brunkwall J: Systematic review and meta-analysis of endovenous radiofrequency obliteration, endove-
nous laser therapy and foam sclerotherapy for primary varicose veins. J Cardiovasc Surg 2008, 49, 213–223.
[31] van den Bos RR, Milleret R, Neumann M, Nijsten T: Proof-of-principle study of steam ablation as novel thermal 
therapy for saphenous varicose veins. J Vasc Surg 2010, 53, 181–186.
[32] Parsi K, Exner T, Connor DE, Herbert A, Ma DDF: The Lytic Effects of Detergent Sclerosants on Erythrocytes, 
Platelets, Endothelial Cells and Microparticles are Attenuated by Albumin and other Plasma Components in Vitro 
Eur J Vasc Endovasc Surg 2008, 36, 216–223.
[33] Sarvananthan T, Shepherd AC, Willenberg T, Davies AH: Neurological complications of sclerotherapy for vari-
cose veins. J Vasc Surg 2012, 55, 243–251.
[34] Elias S, Raines J: Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. 
Phlebology 2012, 27, 67–72.
[35] Wang YM, Cheng LF, Li N: Histopathological study of vascular changes after intra-arterial and intravenous injec-
tion of N- butyl-2-cyanoacrylate. Chin J Dig Dis 2006, 7, 175–179.
[36] Padberg FT Jr, Pappas PJ, Araki CT, Back TL, Hobson RW: Hemodynamic and clinical improvement after 
superficial vein ablation in primary combined venous insufficiency with ulceration. J Vasc Surg 1996, 24, 711–718.
[37] Michaels JA, Campbell WB, Brazier JE: Randomised clinical trial, observational study and assessment of cost-
effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess 2006, 13, 1–196, iii–iv.
[38] Kanwar A, Hansrani M, Lees T, Stansby G: Trends in varicose vein therapy in England. Ann R Coll Surg Engl 
2010, 92, 341–346.
[39] Van Den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T: Endovenous therapies of lower extremity vari-
cosities: a meta-analysis. J Vasc Surg 2009, 49, 230–239.
Address for correspondence:
Maciej Chwała






Conflict of interest: None declared
Received: 27.06.2013
Revised: 23.01.2014
Accepted: 15.10.2014
